Last reviewed · How we verify
NCT04414865
VitaFlow™ Transcatheter Aortic Valve System Post-market Study-The LAUNCH Study
trial testing VitaFlow™ Transcatheter Aortic Valve System in Aortic Valve Stenosis in 100 participants. Currently enrolling.
1 December 2021
Quick facts
| Lead sponsor | Shanghai MicroPort CardioFlow Medtech Co., Ltd. |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 26 April 2020 |
| Primary completion | 1 December 2021 |
| Estimated completion | 30 December 2027 |
| Sites | 2 locations across China |
Drugs / interventions tested
- VitaFlow™ Transcatheter Aortic Valve System
Conditions studied
- Aortic Valve Stenosis — all drugs for Aortic Valve Stenosis →
Sponsor
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Who can join
70 and older, any sex, with Aortic Valve Stenosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study objective is to evaluate safety and effectiveness/performance of the Microport™ CardioFlow VitaFlow™ Transcatheter Aortic Valve System for the treatment of severe aortic stenosis in the real world settings.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04414865
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of VitaFlow™ Transcatheter Aortic Valve System
Trials testing the same drug.
- NCT04655742 — VitaFlow™ Transcatheter Aortic Valve System Pre-market Trial · NA · unknown
Other recruiting trials for Aortic Valve Stenosis
Currently open trials in the same condition.
- NCT07455292 — Phenotyping Left Ventricle Failure With Hemodynamic Biomarkers From 4D Flow Magnetic Resonance Imaging · NA · recruiting
- NCT07008911 — CardioHeartConnect: Commercially Available Fitness for Cardiac Rehabilitation · NA · recruiting
- NCT07145463 — Prospective, Multicenter, Randomized Controlled Clinical Study Evaluating the VitaFlow Liberty® Flex Transcatheter Aorti · NA · recruiting
- NCT07520656 — Impact of Transcatheter Aortic Valve Implantation and Mitral Valve Repair on Sleep-Disordered Breathing · recruiting
- NCT07267117 — Cohort Observing Mechanisms, Progression and Sequelae of Valvular Heart Disease · recruiting
Other Shanghai MicroPort CardioFlow Medtech Co., Ltd. trials
Trials by the same sponsor.
- NCT06597188 — TAVR vs. SAVR Study of VitaFlow Liberty® for Severe BAV Stenosis · NA · enrolling by invitation
- NCT07304427 — Alwide Plus China Post-market Clinical Investigation · completed
- NCT05977257 — VitaFlow® Transcatheter Aortic Valve Replacement System Pre-market Trial Long Term Follow Up （VITAL） · not yet recruiting
- NCT04414878 — VitaFlow™ II Transcatheter Aortic Valve System Pre-market Trial · NA · recruiting
- NCT04655742 — VitaFlow™ Transcatheter Aortic Valve System Pre-market Trial · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04414865 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shanghai MicroPort CardioFlow Medtech Co., Ltd.
- Last refreshed: 4 June 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04414865.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing